Share
451 Posts.
lightbulb Created with Sketch. 105
clock Created with Sketch.
16/05/18
20:51
Share
Originally posted by DrKnow
↑
The basic problem after they disclosed paying that guy on twitter to promote the stock (1 million shares note feb 12, 2018 asx disclosure) and having to cancel the additional payments to Everblu, everyone is skeptical of announcements and what they are really doing / are they acting in best interests of shareholders or others ? Very simple fix / deliver real progress with products and revenues and licenses. The vet products are a great example of real progress and they should be commended for that progress The announcement today appeared way too early in my opinion to be meaningful and putting stock onto halt for 3 days to build some kind of tension or significance risks appearing disingenuous I see someone slightly less generous described it as vacuous It detracted again from credibility of board in my opinion A much simpler announcement with little or no trading halt would have been a much more positively received outcome To tag the holt as "price sensitive" seemed ambitious in my opinion Maybe..... You should elect me as an independent director and I would knock some sense into board Don't get me wrong, I think Miri is outstanding and she should be very successful / this could be a great story. I am lucky and have been out since the AFR articles and won't be back until I see a change in meaningful progress and an end to meaningless announcements (eg the worst one was maybe that announcement on China distribution / half baked and what since ?) You're only as good as your next announcement- I hope in this case we see real progress and share price will respond I am sure
Expand
I think this is a fair summary of the current skepticisim around anns. The fact that we are seeing sales from anibidiol and cannaQIX as well as the progress of Mernova (with photos)are enough to alleviate my doubt, but I can understand the other side.